The development and implementation of pathological parameters and molecular testing impact prognosis of colorectal adenocarcinoma [0.03%]
病理参数和分子检测对结直肠腺癌预后的影响及实施发展研究
Midie Xu,Yaqi Li,Yingxue Liu et al.
Midie Xu et al.
Objective: This study aims to analyze how changes in pathological diagnosis practice and molecular detection technology have affected clinical outcomes for colorectal cancer (CRC) patients in Fudan University Shanghai Can...
How to properly evaluate cardiac vagal tone in oncology studies: a state-of-the-art review [0.03%]
肿瘤学研究中正确评估心脏迷走神经张力的现状及展望：综述文章
Pierrick Martinez,Marilyne Grinand,Saïda Cheggour et al.
Pierrick Martinez et al.
Heart rate variability (HRV) analysis provides an assessment of cardiac vagal tone and consequently global cardiac health as well as systemic condition. In systemic diseases such as cancer and during treatments that affect the whole body, l...
Chinese quality control indices for standardized diagnosis and treatment of renal cancer (2022 edition) [0.03%]
中国肾癌规范化诊治质量控制指标（2022版）
Lin Yao,Yicong Du,Wen Dong et al.
Lin Yao et al.
Renal cancer is one of the most common malignancies of the urinary system, and the number of deaths continues to increase. The standardized management of the diagnosis and treatment of renal cancer is challenging due to the great difference...
Pengliang Wang,Bin Ke,Gang Ma
Pengliang Wang
Bingfeng Han,Rongshou Zheng,Hongmei Zeng et al.
Bingfeng Han et al.
Background: The National Cancer Center (NCC) of China regularly reports the nationwide statistics on cancer incidence and mortality in China. The International Agency for Research on Cancer (IARC) calculates and publishes...
The breast cancer tumor microenvironment and precision medicine: immunogenicity and conditions favoring response to immunotherapy [0.03%]
乳腺肿瘤微环境和精准医疗：免疫原性和有利于响应免疫治疗的条件
Andrea Nicolini,Paola Ferrari,Roberto Silvestri et al.
Andrea Nicolini et al.
Some main recent researches that have dissected tumor microenvironment (TME) by imaging mass cytometry (IMC) in different subtypes of primary breast cancer samples were considered. The many phenotypic variants, clusters of epithelial tumor ...
The role of radiotherapy in patients with refractory Hodgkin's lymphoma after treatment with brentuximab vedotin and/or immune checkpoint inhibitors [0.03%]
布伦妥木单抗和/或免疫检查点抑制剂治疗后复发难治的经典型霍奇金淋巴瘤患者的放疗地位探讨
Ruizhi Zhao,Han Shao,Guiqing Shi et al.
Ruizhi Zhao et al.
Background: Approximately 10%-30% of patients with Hodgkin's lymphoma (HL) experience relapse or refractory (R/R) disease after first-line standard therapy. Brentuximab vedotin (BV) and immune checkpoint inhibitors (ICIs)...
Interpretation of specification for breast cancer screening, early diagnosis, and treatment management in Chinese women [0.03%]
中国女性乳腺癌筛查、早诊早治规范的解读
Fei Ma,Jiong Wu,Li Fu et al.
Fei Ma et al.
Breast cancer has become the most common malignant tumor worldwide. However, the survival rate of breast cancer patients in China is 8% lower compared to that in European and American countries. Insufficient screening coverage and low rate ...
Durable clinical response to the multidisciplinary management of neurosurgery, radiation and chemoimmunotherapy in a patient with PD-L1/PD-L2/JAK2 (PDJ)-amplified, refractory triple-negative breast cancer [0.03%]
放射治疗和化疗免疫疗法多学科协作模式对PD-L1/PD-L2/JAK2（PDJ）扩增型三阴性乳腺癌的持久临床疗效：病例报告
Hongyuan Zhao,Weijie Ma,Ruben C Fragoso et al.
Hongyuan Zhao et al.
Patients with refractory metastatic triple-negative breast cancer (mTNBC) and symptomatic brain metastases have poor prognosis and are challenging to treat. The addition of an programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (P...
Trends in high-risk rates and screening rates for the population-based cancer screening program on esophageal, stomach and liver cancer in China, 2010-2016 [0.03%]
中国食管、胃和肝癌人群癌症筛查项目中高风险率及筛查率的变化趋势（2010—2016年）
Jiang Li,He Li,Hongmei Zeng et al.
Jiang Li et al.
Background: A population-based cancer screening program in rural China, targeting three types of cancer that are most prevalent in these areas, including esophageal, stomach, and liver cancer was awarded by the government...